Mikra Applies to Health Canada for CELLF 2.0 NPN


TORONTO, July 08, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B0) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness, reports that its U.S. biosciences subsidiary Mikra Cellular Sciences Inc. (“Mikra”) has filed a Natural Health Product License Application (“PLA”) with Health Canada, seeking a Natural Product Number (“NPN”) for its best-selling cellular health product CELLF 2.0.

“We’re pleased to announce that Mikra has applied to Health Canada for an NPN for CELLF 2.0,” said Andrea Judge, CEO of Mikra. “Receiving this NPN will allow us to market and promote CELLF 2.0 throughout Canada, both directly and via multiple other sales channels. We look forward to successfully navigating the Health Canada application process and wish to thank our experienced advisors at KGK Science Inc. for their sound guidance throughout the preparation and drafting of our application.”

CELLF 2.0 provides a complete adult daily dose of Pyrroloquinoline Quinone (PQQ) and Glutathione, alongside the recommended dose of bioavailable CoQ10, in a liposomal gel that is precision engineered to protect all of these key molecules from the corrosive effects of stomach acid, delivering them safely to be absorbed by the small intestine and guaranteeing that the full clinical dose becomes bioavailable. The latest published research confirms the vital role played by CELLF 2.0’s key ingredients.

In 2023 a double-blind, randomized controlled trial completed in Japan found1:

After 12 weeks, the participants showed improvements in composite memory and verbal memory... In younger adults (aged 20-40 years), PQQ improved cognitive function (cognitive flexibility, processing speed, and execution speed) after 8 weeks... Older adults (aged 41-65 years) showed improvements in complex and verbal memory after 12 weeks.

In 2023 a study conducted jointly at Canadian and Chinese research universities concluded2:

This study reveals the underlying mechanism of PQQ's strong antioxidant capacity and provides evidence for PQQ as a potential agent for clinical prevention and treatment of natural aging-induced osteoporosis.

In 2023 a comprehensive research review completed at a medical university in Italy determined3:

There is evidence of enhanced glutathione levels in elderly subjects with excellent physical and mental health status, suggesting that heightened glutathione may be a marker and even a causative factor of increased healthspan and lifespan. Such aspects, and much more including glutathione-boosting substances administrable to humans, are considered in this state-of-the-art review, which deals with glutathione and glutathione-dependent enzymes from biochemistry to gerontology, focusing attention also on lifespan/healthspan extension and successful aging; the significance of glutathione levels in aging is considered also in relation to therapeutic possibilities and supplementation strategies... Aimed at increasing glutathione and related defenses to improve health status and counteract aging processes in humans.

CELLF 2.0 is a clinically validated formula proven to boost energy and focus on a cellular level, while protecting against the negative effects of oxidative stress. Meticulously researched, the precision-engineered formula is designed to add healthy, energetic years to your life, so you can feel better, longer. Lifeist is committed to bringing natural products backed by real science to market and looks forward to reaching many more customers in 2024.

About Lifeist Wellness Inc.

Sitting at the forefront of the post-pandemic wellness revolution, Lifeist leverages advancements in science and technology to build breakthrough companies that transform human wellness. Portfolio business units include Mikra, a biosciences and consumer wellness company developing and selling innovative products for cellular health, and CannMart, which operates a B2B wholesale distribution business facilitating recreational cannabis sales to Canadian provincial government control boards including for CannMart Labs, a BHO extraction facility producing high margin cannabis 2.0 products.

Information on Lifeist and its businesses can be accessed through the links below:

www.lifeist.com
https://wearemikra.com/
https://cannmart.com

Contact:
Meni Morim
CEO

Lifeist Wellness Inc.

Ph: 647-362-0390
Email: ir@lifeist.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.

Forward Looking Information

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not historical in nature contain forward-looking information. Forward-looking information can be identified by words or phrases such as “may”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen.

The forward-looking information contained herein, including, without limitation, statements related to Mikra reaching additional customers in 2024, are made as of the date of this news release and are based on assumptions management believed to be reasonable at the time such statements were made, including without limitation, the effectiveness and benefits of CELLF 2.0 are as anticipated, customer interest in Mikra’s products including CELLF 2.0 and resulting sales will be as anticipated, its expectation that the nutraceutical market will develop as currently anticipated, the nutraceutical market will continue to be a multi-billion dollar high-margin market, the introduction of new products and brands will generate additional revenue, expectations that CELLF, CELLF 2.0, RESCUE, SERENITY, PROTECT and other new nutraceutical products to be developed by Mikra will gain market acceptance along with the expansion of the market for nutraceutical products, as well as other considerations that are believed to be appropriate in the circumstances. While we consider these assumptions to be reasonable based on information currently available to management, there is no assurance that such expectations will prove to be correct. By its nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct, and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this news release. Such factors include, without limitation: customer uptake and resulting sales of CELLF 2.0 failing to materialize as anticipated, the inability of the Company to develop Mikra’s business as anticipated, unanticipated changes to current regulations that would adversely impact Mikra’s business, unforeseen developments that would delay Mikra’s ability to sell newly developed nutraceutical products, the risk that the expected demand for nutraceutical products in general and those of Mikra in particular does not develop as anticipated and risks relating to the Company’s ability to execute its business strategy and the benefits realizable therefrom. Additional risk factors can also be found in the Company’s current MD&A filed under the Company’s SEDAR+ profile at www.sedarplus.ca. Readers are cautioned not to put undue reliance on forward-looking information. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable law. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

Source: Lifeist Wellness Inc.

1 Pyrroloquinoline quinone improves brain function in both younger and older adults
https://pubmed.ncbi.nlm.nih.gov/36807425/

2 Pyrroloquinoline quinone alleviates natural aging-related osteoporosis
https://pubmed.ncbi.nlm.nih.gov/37365714/

3 Glutathione and glutathione-dependent enzymes: From biochemistry to gerontology and successful aging
https://pubmed.ncbi.nlm.nih.gov/37683986/